Description

ProgrammeThursday 21 March10:00–10:30 Registration and Refreshments10:30–10:40 IntroductionProfessor Chris Hollis (Nottingham) 10:40–11:25 Behavioural pharmacology in the developing brainProfessor Charles Marsden (Nottingham) 11:25–12:10 Atypical antipsychotics in psychoses and other developmental disordersProfessor Chris Hollis 12:10–12:25 Q&A session12:25–13:30 Lunch in the Plaza Suite13:30–14:15 Drug management of epilepsy and psychiatric complications in children: Exploding the mythsProfessor Frank Besag (Bedford) 14:15–14:30 Q&A session14:30–15:15 Update on pharmacotherapy for ADHDDr Samuele Cortese (Southampton) 15:15–15:30 Q&A session15:30–16:00 RefreshmentsPlease remove all bags, coats and folders from desks16:00–17:00 GroupsGroup 1: ADHDDr Samuele CorteseGroup 2: Bipolar Disorder / Mood StabilizersDr Aditya Sharma (Newcastle) 17:00–17:10 Comfort break and presenters change rooms17:10–18:10 GroupsGroup 1: Bipolar Disorder / Mood StabilizersDr Aditya SharmaGroup 2: ADHDDr Samuele Cortese 18:10 End of Thursday SessionsFriday 22 March08:30–08:45 Arrival and refreshments08:45–09:15 Tourette’s SyndromeDr Isobel Heyman (London) 09:15–09:25 Q&A session09:25–09:55 Paediatric Psychopharmacology for OCDDr Bruce Clark (London) 09:55–10:00 Q&A session10:00–10:45 Anxiety and Mood DisordersDr Paul Wilkinson (Cambridge) 10:45–11:00 Q&A session11:00–11:30 Refreshments11:30–12:15 Autistic Spectrum Disorder – Comorbidity and PharmacotherapyDr Paramala Santosh (London) 12:15–12:30 Q&A session12:30–13:15 Lunch in the Plaza SuitePlease remove all bags, coats and folders from desks13:15–14:15 Group Work (delegates choose two out of three groups)Group A: Autistic Spectrum DisorderDr Paramala SantoshGroup B: Tourette’sProfessor Chris Hollis (Nottingham) and Mr Joe Kilgariff (Nottingham)Group C: Anxiety and DepressionDr Paul Wilkinson 14:15–14:45 Refreshments and delegates change rooms14:45–15:45 Group Work Session 2Group A: Autistic Spectrum DisorderDr Paramala SantoshGroup B: Tourette’sProfessor Chris Hollis and Mr Joe KilgariffGroup C: Anxiety and DepressionDr Paul Wilkinson 15:45 End of MeetingLast edited 20th September 2018Learning ObjectivesAt the end of the module, delegates would be expected:to be aware of the issues of drug treatments and the developing brain;to be updated on recent advances in the drug treatment of psychoses in children and adolescents;to be aware of the advances in understanding the neurobiology of depression in young people and the role of SSRIs and other new antidepressants;to be updated on the use of drugs in the treament of Tourette’s syndrome and OCD in children and adolescents;to have the opportunity to raise questions with a panel of experts;to have the opportunity to join practical workshops on prescribing;to learn how to critically appraise the evidence for drug treatments in children and adolescentsThis module is eligible for 10 CPD hours which are subject to peer group review.